Abstract
The biocatalytic production of pravastatin from compactin by hydroxylation has found many applications in health care and pharmaceuticals. Actinomadura macra, Actinomadura madurae, and Actinomadura livida can efficiently bioconvert compactin to pravastatin. The fermentation broth (Penicillium citrinum fermented media) harvested on the eighth day contained 388.90 mg L−1 of compactin and an undetectable level of mycotoxin (citrinin). Bioconversion by A. macra was highest (87 %) in the yeast extract-amended medium. The anti-actinomadura effects of citrinin reduce the bioconversion capacity of Actinomadura. The in situ hydroxylation of compactin produced by P. citrinum represents a preferable alternative for the use of purified compactin, as a way to reduce cost and time processing.
References
Ahmad, A., Mujeeb, M., & Panda, B. P. (2010). An HPTLC method for the simultaneous analysis of compactin and citrinin in Penicillium citrinum fermentation broth. Journal of Planar Chromatography — Modern TLC, 23, 282–285. DOI: 10.1556/jpc.23.2010.4.8.
Ahmad, A., Mujeeb, M., & Panda, B. P. (2011a). Production and optimization of mevastatin by Penicillium citrinum MTCC 1256 and effect of citrinin on growth of Actinomadura strains. Latin American Journal of Pharmacy, 30, 496–501.
Ahmad, A., Panda, B. P., & Mujeeb, M. (2011b). A validated stability-indicating method for simultaneous analysis of mevastatin and pravastatin in fermentation broth during bioconversion by Actinomadura macra. Acta Chromatographica, 23, 121–131. DOI: 10.1556/achrom.23.2011.1.8.
Barrios-González, J., & Miranda, R. U. (2010). Biotechnological production and applications of statins. Applied Microbiology and Biotechnology, 85, 869–883. DOI: 10.1007/s00253-009-2239-6.
Chakravarti, R., & Sahai, V. (2002a). A chemically defined medium for production of compactin by Penicillium citrinum. Biotechnology Letters, 24, 527–530. DOI: 10.1023/a:1014895532142.
Chakravarti, R., & Sahai, V. (2002b). Optimization of compactin production in chemically defined production medium by Penicillium citrinum using statistical methods. Process Biochemistry, 38, 481–486. DOI: 10.1016/s0032-9592(02)00 138-3.
Chan, W. H. (2008). Effects of citrinin on maturation of mouse oocytes, fertilization, and fetal development in vitro and in vivo. Toxicology Letters, 180, 28–32. DOI: 10.1016/j.toxlet.2008.05.011.
Chen, C. H., Hu, H. Y., Cho, Y. C., & Hsu, W. H. (2006). Screening of compactin-resistant microorganisms capable of converting compactin to pravastatin. Current Microbiology, 53, 108–112. DOI: 10.1007/s00284-005-0276-7.
Hosobuchi, M., Kurosawa, K., & Yoshikawa, H. (1993). Application of computer to monitoring and control of fermentation process: Microbial conversion of ML-236B Na to pravastatin. Biotechnology and Bioengineering, 42, 815–820. DOI: 10.1002/bit.260420705.
Jackson, L. K., & Ciegler, A. (1978). Production and analysis of citrinin in corn. Applied and Environmental Microbiology, 36, 408–411.
Lin, C. L., Tang, Y. L., & Lin, S. M. (2011). Efficient bioconversion of compactin to pravastatin by the quinolinedegrading microorganism Pseudonocardia carboxydivorans isolated from petroleum-contaminated soil. Bioresource Technology, 102, 10187–10193. DOI: 10.1016/j.biortech.2011.09.029.
Park, J. W., Lee, J. K., Kwon, T. J., Yi, D. H., Kim, Y. J., Moon, S. H., Suh, H. H., Kang, S. M., & Park, Y. I. (2003). Bioconversion of compactin into pravastatin by Streptomyces sp. Biotechnology Letters, 25, 1827–1831. DOI: 10.1023/a:1026281914301.
Peng, Y. L., & Demain, A. L. (1998). A new hydroxylase system in Actinomadura sp cells converting compactin to pravastatin. Journal of Industrial Microbiology & Biotechnology, 20, 373–375. DOI: 10.1038/sj.jim.2900539.
Peng, Y. L., & Demain, A. L. (2000). Bioconversion of compactin to pravastatin by Actinomadura sp. ATCC 55678. Journal of Molecular Catalysis B: Enzymatic, 10, 151–156. DOI: 10.1016/s1381-1177(00)00123-5.
Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macferlane, P. W., McKillop, J. H., & Packard, C. J. (1995). Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. New England Journal of Medicine, 333, 1301–1309. DOI: 10.1056/nejm199511163332001.
Watanabe, I., Nara, F., & Serizawa, N. (1995). Cloning, characterization and expression of the gene encoding cytochrome P-450sca-in2 from Streptomyces carbophilus involved in production of pravastatin, a specific HMG-CoA reductase inhibitor. Gene, 163, 81–85. DOI: 10.1016/0378-1119(95)00394-l.
Yamashita, H., Tsubokawa, S., & Endo, A., (1985). Microbial hydroxylation of compactin (ML-236B) and monacolin K. Journal of Antibiotics, 38, 605–609.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Ahmad, A., Mujeeb, M., Kapoor, R. et al. In situ bioconversion of compactin to pravastatin by Actinomadura species in fermentation broth of Penicillium citrinum . Chem. Pap. 67, 667–671 (2013). https://doi.org/10.2478/s11696-013-0323-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.2478/s11696-013-0323-y